People | February 14, 2023
Sanofi announces change in R&D leadership
Dr. Dietmar Berger, has agreed to take the leadership of the team ad interim
Dr. Dietmar Berger, has agreed to take the leadership of the team ad interim
The company has announced net revenue of Rs. 639.8 crore for Q3 FY23 as compared to Rs. 562.08 crore in the corresponding period of the previous year
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
Profit after Tax stood at Rs. 106 crore as compared to Rs. 84 crore registering growth of 26%
The WHO has urged China to increase adoption of mRNA vaccines, given their high efficacy against variant strains.
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
The issue with a face value of Rs 10 per equity share consists of a fresh issue of equity shares worth up to Rs 400 crore
The company will not receive any proceeds from the offer as all of it will go to the promoter selling shareholder.
The top 15 Indian pharma players have continued to experience anaemic growth in the US market over the five years ended FY22
Biocytogen will provide a license to Hansoh Pharma for their selected fully human antibody molecules
Subscribe To Our Newsletter & Stay Updated
